Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Federica, Bovo"'
Publikováno v:
Antibiotics, Vol 12, Iss 12, p 1707 (2023)
The novel β-lactam/β-lactamase inhibitor combinations (βL-βLICs) are one of the last-line resources available against multidrug-resistant (MDR) Gram-negative bacteria. Among βL-βLICs, ceftazidime/avibactam (CAZ-AVI) demonstrated strong activity
Externí odkaz:
https://doaj.org/article/32751cf28a9c4d12a1aabff4bf9bec61
Autor:
Paolo Gaibani, Elisa Viciani, Michele Bartoletti, Russell E. Lewis, Tommaso Tonetti, Donatella Lombardo, Andrea Castagnetti, Federica Bovo, Clara Solera Horna, Marco Ranieri, Pierluigi Viale, Maria Carla Re, Simone Ambretti
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract COVID-19 infection may predispose to secondary bacterial infection which is associated with poor clinical outcome especially among critically ill patients. We aimed to characterize the lower respiratory tract bacterial microbiome of COVID-19
Externí odkaz:
https://doaj.org/article/e865db79ecc6435cb50c8af93034831e
Publikováno v:
Antibiotics, Vol 12, Iss 5, p 858 (2023)
Limited treatment options are among the main reasons why antimicrobial resistance has become a leading major public health problem. In particular, carbapenem-resistant Enterobacteriales (CRE), Pseudomonas aeruginosa and Acinetobacter baumannii have b
Externí odkaz:
https://doaj.org/article/d9886b9df7134c319689e245b0adba7b
Publikováno v:
Antibiotics, Vol 12, Iss 3, p 614 (2023)
The aim of this study was to compare the reference broth microdilution (BMD) method with the Disk Diffusion (DD) test and strip test against a collection of 75 well-characterized Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoni
Externí odkaz:
https://doaj.org/article/0ec2bd5ab0ec46fea380da1954cdca7d
Publikováno v:
Antibiotics, Vol 11, Iss 11, p 1621 (2022)
The management of KPC-producing K. pneumoniae (KPC-Kp) in bloodstream infections (BSIs) represent a serious clinical challenge. In this study, the aim is to assess the incidence of resistance to novel β-lactams-β-lactamase inhibitor combinations (
Externí odkaz:
https://doaj.org/article/24d6e9f7421a455aa3a668dd09a954c3
Autor:
Paolo Gaibani, Tommaso Giani, Federica Bovo, Donatella Lombardo, Stefano Amadesi, Tiziana Lazzarotto, Marco Coppi, Gian Maria Rossolini, Simone Ambretti
Publikováno v:
Antibiotics, Vol 11, Iss 5, p 628 (2022)
Multidrug resistance (MDR) represents a serious global threat due to the rapid global spread and limited antimicrobial options for treatment of difficult-to-treat (DTR) infections sustained by MDR pathogens. Recently, novel β-lactams/β-lactamase in
Externí odkaz:
https://doaj.org/article/838aaff283b94d7d911402bb55442130
Autor:
Paolo Gaibani, Linda Bussini, Stefano Amadesi, Michele Bartoletti, Federica Bovo, Tiziana Lazzarotto, Pierluigi Viale, Simone Ambretti
Publikováno v:
Microorganisms, Vol 10, Iss 4, p 778 (2022)
Novel carbapenem-β-lactamase inhibitor combination, imipenem/relebactam (IMI-REL), has been recently approved for treatment of infections with limited or no alternative treatment options. In this study, we described the emergence of the IMI-REL-resi
Externí odkaz:
https://doaj.org/article/7574890a19c14cbe9057c11f780144ee
Autor:
Paolo Gaibani, Donatella Lombardo, Linda Bussini, Federica Bovo, Beatrice Munari, Maddalena Giannella, Michele Bartoletti, Pierluigi Viale, Tiziana Lazzarotto, Simone Ambretti
Publikováno v:
Antibiotics, Vol 10, Iss 5, p 536 (2021)
Meropenem/Vaborbactam (MEM-VAB) is a novel carbapenem- β-lactamase inhibitor active against KPC-producing Enterobacteria. Herein, we evaluate the incidence of meropenem/vaborbactam-resistance among KPC-producing K. pneumoniae (KPC-Kp) bloodstream in
Externí odkaz:
https://doaj.org/article/aa12c1a66bbb488c853b2eb06eb02ed4
Autor:
Giulia Pensalfine, Linda Bussini, Lucia Appolloni, Simone Ambretti, Pierluigi Viale, Russell E. Lewis, Michele Bartoletti, Sara K. Tedeschi, Fabio Tumietto, Maddalena Giannella, Federica Bovo, Renato Pascale, Giacomo Fornaro, Donatella Lombardo, Paolo Gaibani
Publikováno v:
Infection Control and Hospital Epidemiology
Objective:To assess the incidence of colonization and infection with carbapenemase-producing Enterobacteriaceae (CPE) and carbapenem-resistant Acinetobacter baumannii (CR-Ab) in the ICUs of our city hospitals before and during the coronavirus disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba222ff215281dc6dfba539c06112e1b
http://europepmc.org/articles/PMC8365044
http://europepmc.org/articles/PMC8365044
Autor:
Paolo Gaibani, Federica Bovo, Linda Bussini, Michele Bartoletti, Tiziana Lazzarotto, Pierluigi Viale, Federico Pea, Simone Ambretti
Publikováno v:
Clinical Microbiology and Infection. 29:654.e1-654.e4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14aa1bf0cdde6ba9f987cedadfa2da11
https://doi.org/10.1016/j.cmi.2023.01.012
https://doi.org/10.1016/j.cmi.2023.01.012